A new series of amino-acetonitrile derivatives (AAD) have been discovered that exhibit high anthelmintic activity against parasitic nematode species such as Haemonchus contortus and Trichostrongylus colubriformis. Significantly, these compounds also demonstrate activity against nematode strains resistant to the currently available broad-spectrum anthelmintics. The discovery, synthesis, structure-activity
COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE
申请人:SHY Therapeutics LLC
公开号:US20170174699A1
公开(公告)日:2017-06-22
Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are useful in compositions and methods for treating cancer and inflammatory disease.
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
申请人:Shy Therapeutics LLC
公开号:US11000515B2
公开(公告)日:2021-05-11
Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE
申请人:Shy Therapeutics LLC
公开号:US20200061037A1
公开(公告)日:2020-02-27
Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
[EN] COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DU CANCER ET DE MALADIES INFLAMMATOIRES
申请人:SHY THERAPEUTICS LLC
公开号:WO2017112777A1
公开(公告)日:2017-06-29
Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are compositions and methods for treating cancer and inflammatory disease.